Loading…
Clover Health Investments, Corp. is projected to rise to $4.56 by 2027, a +27% move from its current price of $3.59. CLOV is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.49 | $3.59 | $3.70 | +0.05% |
| May 30 | $3.45 | $3.59 | $3.74 | +0.10% |
| May 31 | $3.42 | $3.60 | $3.78 | +0.15% |
| Jun 1 | $3.40 | $3.60 | $3.81 | +0.20% |
| Jun 2 | $3.38 | $3.60 | $3.83 | +0.25% |
| Jun 3 | $3.36 | $3.60 | $3.86 | +0.30% |
| Jun 4 | $3.34 | $3.60 | $3.88 | +0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.34 | $3.60 | $3.88 | +0.35% |
| Week 2 | $3.25 | $3.62 | $4.02 | +0.70% |
| Week 3 | $3.19 | $3.63 | $4.13 | +1.06% |
| Week 4 | $3.13 | $3.64 | $4.23 | +1.41% |
| Week 5 | $3.09 | $3.65 | $4.32 | +1.77% |
| Week 6 | $3.05 | $3.67 | $4.41 | +2.12% |
| Week 7 | $3.02 | $3.68 | $4.49 | +2.48% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals.
It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Clover Health Investments, Corp. trades in the healthcare sector under the CLOV ticker.
The current price is $3.55 and the company has a market capitalization of $1.87B with a market rank of 2050.
The long-run forecast shows a rising trajectory, with 2026 avg $3.55 and 2050 avg $73.90 and a 2050 max $141.63.
Across the horizon, the average price climbs from $3.55 in 2026 to $73.90 in 2050, with a max projection of $141.63 in 2050, indicating a substantial upside from the current level.
A major floor 53.9% below — a decisive break under it would weaken the trend.
The nearest floor, 40.1% below — buyers have tended to step in here.
Price is pressing into resistance (0.6% away) — a breakout level to watch.
A major ceiling 27.5% above — clearing it would confirm fresh momentum.
Key CLOV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CLOV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.59 | Buy | $3.57 | Buy |
| MA 10 | $3.53 | Buy | $3.47 | Buy |
| MA 20 | $3.19 | Buy | $3.22 | Buy |
| MA 50 | $2.49 | Buy | $2.76 | Buy |
| MA 100 | $2.37 | Buy | $2.57 | Buy |
| MA 200 | $2.57 | Buy | $2.61 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 76.04 | Sell |
| Stoch RSI (14) | 18.43 | Buy |
| CCI (20) | 75.13 | Neutral |
| Williams %R (14) | -2.53 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 15.06 | Buy |
| Bollinger %B (20,2) | 0.76 | Neutral |
| Stochastic %K (14) | 97.47 | Sell |
| TRIX (15) | 1.87 | Buy |
| Awesome (5,34) | 0.79 | Buy |
| Ultimate (7,14,28) | 71.75 | Sell |
| Momentum (10) | 0.31 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 3.62 | Sell |
| ADX (14) | 50.97 | Buy |
| ATR (14) | 0.08 | Info |
The 30-day technical picture is BULLISH, with RSI14 at 80.
The stock trades above its moving averages, with SMA50 at $2.42 and SMA200 at $2.55.
Support is $2.03 and resistance is $3.60; the 30-day price range runs from $2.91 to $4.32.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.70 | $3.59 | $5.15 | 0% | Neutral | |
| $3.60 | $4.56 | $6.13 | +27% | Bullish | |
| $4.18 | $5.44 | $7.58 | +52% | Bullish | |
| $5.33 | $7.10 | $10.19 | +98% | Bullish | |
| $6.31 | $8.60 | $12.64 | +140% | Bullish | |
| $7.80 | $10.82 | $16.26 | +201% | Bullish | |
| $9.05 | $12.79 | $19.59 | +256% | Bullish | |
| $8.96 | $12.88 | $20.07 | +259% | Bullish | |
| $9.96 | $14.55 | $23.05 | +305% | Bullish | |
| $11.31 | $16.79 | $26.99 | +368% | Bullish | |
| $18.77 | $29.87 | $51.16 | +732% | Bullish | |
| $41.63 | $74.85 | $140.52 | +19.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.70 | $3.59 | $4.22 | +0.00% |
| June 2026 | $3.08 | $3.62 | $4.36 | +0.89% |
| July 2026 | $3.17 | $3.76 | $4.59 | +3.74% |
| August 2026 | $3.30 | $3.94 | $4.86 | +4.91% |
| September 2026 | $3.29 | $3.94 | $4.91 | +0.06% |
| October 2026 | $3.23 | $3.90 | $4.89 | -1.19% |
| November 2026 | $3.29 | $3.99 | $5.04 | +2.41% |
| December 2026 | $3.32 | $4.05 | $5.15 | +1.41% |
Click any year to see its month-by-month CLOV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CLOV could reach as high as $5.15, with a base case around $3.59 and support toward $1.70 — roughly 0% from $3.59. A consolidation phase looks the most probable path here.
Expect CLOV to range from $3.60 to $6.13 through 2027. The $4.56 average target implies a +27% move from current prices. That is up +27% on the projected 2026 average. Momentum favours further upside here.
The CLOV price prediction for 2028 points to an average of $5.44 (low $4.18, high $7.58) — a potential gain of +52% on today's $3.59. Buyers look set to stay in control over this stretch.
In 2029, CLOV is projected to trade between $5.33 and $10.19, averaging $7.10 — a potential gain of +98% from today's $3.59. That is up +31% on the projected 2028 average. Momentum favours further upside here.
Clover Health Investments, Corp.'s 2030 outlook centres on $8.60, within a $6.31 to $12.64 range. That is up +21% on the projected 2029 average. That marks a +140% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, CLOV could reach as high as $16.26, with a base case around $10.82 and support toward $7.80 — roughly +201% from $3.59. Momentum favours further upside here.
Expect CLOV to range from $9.05 to $19.59 through 2032. The $12.79 average target implies a +256% move from current prices. That is up +18% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The CLOV price prediction for 2033 points to an average of $12.88 (low $8.96, high $20.07) — a potential gain of +259% on today's $3.59. Momentum favours further upside here.
In 2034, CLOV is projected to trade between $9.96 and $23.05, averaging $14.55 — a potential gain of +305% from today's $3.59. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Clover Health Investments, Corp.'s 2035 outlook centres on $16.79, within a $11.31 to $26.99 range. That is up +15% on the projected 2034 average. That marks a +368% change versus current levels. Momentum favours further upside here.
By 2040, CLOV could reach as high as $51.16, with a base case around $29.87 and support toward $18.77 — roughly +732% from $3.59. Buyers look set to stay in control over this stretch.
Expect CLOV to range from $41.63 to $140.52 through 2050. The $74.85 average target implies a +19.8x move from current prices. That is up +151% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CLOV today (≈ 278.551532 CLOV) could be worth
$20,849.91
+$19,849.91 (+1985%) by 2050 · US Dollar
Based on the average projected CLOV price of $74.85 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CLOVwould be worth at today's price.
$1,000 invested in CLOV on May 27, 2025 (≈ 311.526476 CLOV) would be worth
$1,118.38
+$118.38 (+11.8%) today · 1.12× · US Dollar
Based on a CLOV entry price of $3.21 vs. today's $3.59.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.59 | $1,000 | +0.0% |
| 1 month ago | $2.52 | $1,424.6 | +42.5% |
| 3 months ago | $2.15 | $1,669.77 | +67.0% |
| 6 months ago | $2.49 | $1,441.77 | +44.2% |
| 1 year ago | $3.21 | $1,118.38 | +11.8% |
| All time (5.0y) ago | $7.73 | $464.42 | -53.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CLOV forecast.
Our base-case forecast reaches $7.20 around 2030.
Implied market cap at $7.20: $3.1B
2030 forecast shows an average price of $8.55, a min of $6.21 and a max of $12.71, with an ROI of 140.8 and a bullish sentiment.
2040 forecast shows an average price of $29.73, a min of $18.29 and a max of $51.83, with an ROI of 737.6 and a bullish sentiment.
2050 forecast shows an average price of $73.90, a min of $39.83 and a max of $141.63, with an ROI of 1981.6 and a bullish sentiment.
These are estimates, not guarantees. The outlook reflects rising averages over time, but actual results may differ with market conditions.
Tap a question to reveal the answer.
2030 avg $8.55; min $6.21; max $12.71; ROI 140.8; sentiment BULLISH.
The forecast is bullish from 2027 onward, with 2030 avg $8.55 (ROI 140.8%), 2040 avg $29.73 (ROI 737.6%), and 2050 avg $73.90 (ROI 1981.6%). In 2026, the avg is $3.55 with ROI 0 and sentiment NEUTRAL.
Yes; the forecast max in 2050 is $141.63.
Current price is $3.55; market cap is $1.87B.
30-day range is $2.91 to $4.32; RSI14 is 80.
Clover Health Investments, Corp. Community Discussion
0Share your Clover Health Investments, Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.